Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Medical Sciences Division News

Oxford to advance mental health research through £1.5 million gift

The University of Oxford has received a £1.5 million gift from Bukhman Philanthropies to support new research aiming to tackle one of the most pressing challenges of our time – young people’s mental health.

The Oxford-Harrington Rare Disease Centre advances discovery of therapies for Friedreich’s Ataxia (FA)

Philanthropic funding from the Friedreich's Ataxia Alliance Innovation Fund awarded to five Oxford researchers to support development of novel therapeutics.

Public trust in health data sharing for AI is conditional

Public support for sharing health data for artificial intelligence (AI) research depends on clear public benefit, strong safeguards, and meaningful consent, according to a new Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) study based on in-depth focus groups with members of the UK public.

The changing face of heart disease: Why it’s time to rethink prevention

For decades, heart disease prevention has been one of the biggest public health success stories. Thanks to research and better awareness about risks like high blood pressure, smoking, and cholesterol, rates of heart attacks and strokes have fallen dramatically since the 1960s. But in recent years, this progress has slowed, and in some countries, even reversed.

Statins do not cause the majority of side effects listed in package leaflets

Statins do not cause the majority of the conditions that have been listed in their package leaflets, including memory loss, depression, sleep disturbance, and erectile and sexual dysfunction, according to the most comprehensive review of possible side effects. The study was led by researchers at the Nuffield Department of Population Health and published in The Lancet.